Journey Interest Expense from 2010 to 2025

DERM Stock  USD 4.55  0.57  14.32%   
Journey Medical Interest Expense yearly trend continues to be very stable with very little volatility. Interest Expense is likely to drop to about 1.9 M. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2014-12-31
Previous Quarter
563 K
Current Value
758 K
Quarterly Volatility
1.6 M
 
Yuan Drop
 
Covid
Check Journey Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Journey Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.7 M, Interest Expense of 1.9 M or Selling General Administrative of 53.8 M, as well as many indicators such as Price To Sales Ratio of 1.45, Dividend Yield of 0.0 or PTB Ratio of 3.5. Journey financial statements analysis is a perfect complement when working with Journey Medical Valuation or Volatility modules.
  
Check out the analysis of Journey Medical Correlation against competitors.

Latest Journey Medical's Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Journey Medical Corp over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Journey Medical's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Journey Medical's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Pretty Stable
   Interest Expense   
       Timeline  

Journey Interest Expense Regression Statistics

Arithmetic Mean2,608,923
Geometric Mean814,563
Coefficient Of Variation162.22
Mean Deviation2,873,279
Median1,540,000
Standard Deviation4,232,318
Sample Variance17.9T
Range15.5M
R-Value0.23
Mean Square Error18.2T
R-Squared0.05
Significance0.40
Slope201,885
Total Sum of Squares268.7T

Journey Interest Expense History

20251.9 M
2024M
20231.7 M
2022M
2021M
2020698 K
2019255 K

About Journey Medical Financial Statements

Journey Medical investors utilize fundamental indicators, such as Interest Expense, to predict how Journey Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Interest ExpenseM1.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
Check out the analysis of Journey Medical Correlation against competitors.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
2.921
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.17)
Return On Equity
(1.30)
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.